查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1339168

肌肉鬆弛剂市场、份额、规模、趋势、产业分析报告：按药物类型、给药途径、分销管道、地区和细分市场预测，2023-2032 年

Muscle Relaxant Drugs Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Skeletal Muscle Relaxant Drugs, Facial Muscle Relaxant Drugs); By Route of Administration; By Distribution Channel; By Region, And Segment Forecasts, 2023-2032
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，到 2032 年，全球肌肉鬆弛剂市场规模预计将达到 56.7 亿美元。 该报告提供了对当前市场动态的详细见解，并对未来市场成长进行了分析。

人们对肌肉鬆弛剂及其益处的认识不断提高，给药技术的进步预计也将推动市场成长。 此外，越来越多地使用包括肌肉鬆弛剂在内的联合疗法作为治疗方案的一部分，预计也将推动未来几年的市场成长。 此外，以较低价格提供通用肌肉鬆弛剂预计也将推动市场成长，特别是在新兴国家。

与工作相关的肌肉骨骼疾病是医护人员的常见问题，而腰痛是最常被通报的投诉之一。 这突显出需要有效的治疗方法（例如肌肉鬆弛剂）来控制这些症状并改善受影响者的生活品质。 因此，对此类药物的需求可能会增加，为市场创造成长机会。

除了 FDA 核准的药物外，还有超适应症用于治疗痉挛和肌肉痉挛的肌肉鬆弛剂，例如苯二氮平类药物、加巴喷丁类药物和鸦片类药物。 然而，这些药物具有很高的副作用风险，并且有可能被滥用，因此不建议在这些情况下使用它们。 重要的是，医疗保健专业人员仔细评估每种药物的风险和益处，并根据个别患者的需求量身定制治疗方案。

副作用是使用肌肉鬆弛剂的重要问题。 这些症状包括嗜睡、头晕、意识混乱、口干和视力模糊。 这些副作用可能很严重，甚至危及生命，并可能限制该行业的发展。 因此，平衡这些药物的益处和潜在风险并根据具体情况仔细评估其使用至关重要。

肌肉鬆弛剂市场报告亮点

由于肌肉骨骼疾病的增加和联合疗法的创新，骨骼鬆弛剂领域占据了最大份额。

由于高处方率和口腔产品的可用性，口腔细分市场拥有很大的市场份额。

由于拥有熟练的医生和护士以及有效的治疗选择，酒店业预计将占据更大的销售份额。

由于存在专门的医疗保健基础设施，预计北美在研究期间将会成长。

目录

第一章简介

第 2 章执行摘要

第三章研究方法

第四章全球肌鬆药市场洞察

  • 肌肉鬆弛剂市场 - 通路概况
  • 肌肉鬆弛剂市场动态
    • 推动者和机会
      • 老年人口增加
      • 肌肉骨骼疾病的盛行率不断上升
    • 抑制因素和挑战
      • 肌肉鬆弛剂的副作用
  • PESTEL 分析
  • 肌鬆药市场通路的趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第 5 章全球肌肉鬆弛剂市场（依药物类型）

  • 主要发现
  • 简介
  • 骨骼肌鬆弛剂
  • 脸部肌肉鬆弛剂
  • 神经肌肉阻断剂

第 6 章全球肌肉鬆弛剂市场（依给药途径）

  • 主要发现
  • 简介
  • 口头
  • 注射剂

第 7 章全球肌肉鬆弛剂市场（依通路）

  • 主要发现
  • 简介
  • 医院药房
  • 零售药局
  • 网路药局
  • 诊断实验室

第 8 章全球肌肉鬆弛剂市场（按地区）

  • 主要发现
  • 简介
    • 2019-2032 年肌肉鬆弛剂市场评估（按地区）
  • 肌肉鬆弛剂市场 - 北美
    • 北美：肌肉鬆弛剂市场，依药物类型，2019-2032 年
    • 北美：肌肉鬆弛剂市场，依通路划分，2019-2032 年
    • 北美：肌肉鬆弛剂市场（依给药途径），2019-2032 年
    • 肌肉鬆弛剂市场 - 美国
    • 肌肉鬆弛剂市场 - 加拿大
  • 肌肉鬆弛剂市场 - 欧洲
    • 欧洲：肌肉鬆弛剂市场（以药物类型），2019-2032 年
    • 欧洲：肌肉鬆弛药物市场，依通路划分，2019-2032 年
    • 欧洲：肌肉鬆弛剂市场（依给药途径），2019-2032 年
    • 肌肉鬆弛剂市场 - 英国
    • 肌肉鬆弛剂市场 - 法国
    • 肌肉鬆弛剂市场 - 德国
    • 肌肉鬆弛剂市场 - 义大利
    • 肌肉鬆弛剂市场 - 西班牙
    • 肌肉鬆弛剂市场 - 荷兰
    • 肌肉鬆弛剂市场 - 俄罗斯
  • 肌肉鬆弛剂市场 - 亚太地区
    • 亚太地区：肌肉鬆弛剂市场，依药物类型，2019-2032 年
    • 亚太地区：肌肉鬆弛药物市场，依通路划分，2019-2032 年
    • 亚太地区：肌肉鬆弛剂市场（依给药途径），2019-2032 年
    • 肌肉鬆弛剂市场 - 中国
    • 肌肉鬆弛剂市场 - 印度
    • 肌肉鬆弛剂市场 - 马来西亚
    • 肌肉鬆弛剂市场－日本
    • 肌肉鬆弛剂市场 - 印度尼西亚
    • 肌肉鬆弛剂市场－韩国
  • 肌肉鬆弛剂市场 - 中东和非洲
    • 中东和非洲：肌肉鬆弛药物市场（按药物类型），2019-2032 年
    • 中东和非洲：2019-2032 年肌肉鬆弛药物市场（按分销管道）
    • 中东和非洲：肌肉鬆弛剂市场（依给药途径），2019-2032 年
    • 肌肉鬆弛剂市场－沙乌地阿拉伯
    • 肌肉鬆弛剂市场 - 阿拉伯联合大公国
    • 肌肉鬆弛剂市场 - 以色列
    • 肌肉鬆弛剂市场 - 南非
  • 肌肉鬆弛剂市场 - 拉丁美洲
    • 拉丁美洲：2019-2032 年肌肉鬆弛药物市场（依药物类型）
    • 拉丁美洲：肌肉鬆弛药物市场，依通路划分，2019-2032 年
    • 拉丁美洲：肌肉鬆弛剂市场，依给药途径划分，2019-2032 年
    • 肌肉鬆弛剂市场 - 墨西哥
    • 肌肉鬆弛剂市场 - 巴西
    • 肌肉鬆弛剂市场－阿根廷

第九章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第十章公司简介

  • Amneal Pharmaceuticals
  • Ipsen Biopharmaceuticals
  • Merz Pharmaceuticals
  • Par Pharmaceutical
  • Endo Pharmaceuticals
  • Vertical Pharmaceuticals
  • Mallinckrodt
  • SteriMax
  • Eisai Co.
  • Metacel Pharmaceuticals
  • Metacel Pharmaceuticals
Product Code: PM3548

The global muscle relaxant drugs market size is expected to reach USD 5.67 billion by 2032, according to a new study by Polaris Market Research. The report "Muscle Relaxant Drugs Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Skeletal Muscle Relaxant Drugs, Facial Muscle Relaxant Drugs); By Route of Administration; By Distribution Channel; By Region, And Segment Forecasts, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Growing awareness about muscle relaxant drugs and their benefits, along with advancements in drug delivery technologies, are also expected to drive market growth. The increasing use of combination therapies that include muscle relaxants as a part of the treatment regimen is also expected to propel market growth in the coming years. Furthermore, the availability of generic versions of muscle relaxants at lower prices is expected to drive market growth, particularly in emerging economies.

Work-related musculoskeletal disorders are a common issue among healthcare workers, and lower back pain is one of the most frequently reported complaints. This highlights the need for effective treatments, such as muscle relaxant drugs, to manage these conditions and improve the quality of life for affected individuals. As a result, the demand for such drugs is likely to increase, which could provide growth opportunities for the market.

In addition to the FDA-approved drugs, there are also other muscle relaxant medications used off-label for spasticity or muscle spasms, including benzodiazepines, gabapentinoids, and opioids. However, their use for these conditions is not recommended as they have a higher risk of adverse effects and abuse potential. It is important for healthcare professionals to carefully evaluate the risks and benefits of each medication and tailor the treatment to the individual patient's needs.

Side effects are a significant concern associated with the use of muscle relaxants. It includes drowsiness, dizziness, confusion, dry mouth, and blurred vision. These side effects can be severe and, in some cases, even life-threatening, which can limit the growth of the industry. Therefore, it is crucial to balance the benefits of these drugs against the potential risks and carefully evaluate their use on a case-by-case basis.

Muscle Relaxant Drugs Market Report Highlights

Skeletal relaxant segment held the largest share, owing to rise in musculo-skeletal disorders, and innovation in combination therapies.

Oral segment accounted for the larger market share owing to their high prescription rate, and availability in products in oral form

Hospital segment is projected to experience larger revenue share, due to the presence skilled doctors and nurses, and effective treatment options

North America is expected to grow over the study period, due to presence of dedicated healthcare infrastructure

The global players include: Amneal Pharmaceuticals, Ipsen Biopharmaceuticals, Merz Pharmaceuticals, Par Pharmaceutical, Endo Pharmaceuticals, Vertical Pharmaceuticals, Mallinckrodt, SteriMax, Eisai Co., Metacel Pharmaceuticals, and Teva Pharmaceuticals.

Polaris Market Research has segmented the muscle relaxant drugs market report based on drug type, route of administration, distribution channel, and region:

Muscle Relaxant Drugs, Drug Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Skeletal Muscle Relaxant Drugs
  • Facial Muscle Relaxant Drugs
  • Neuromuscular Blocking Agents

Muscle Relaxant Drugs, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

  • Oral
  • Injectable

Muscle Relaxant Drugs, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Diagnostic Labs

Muscle Relaxant Drugs, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Distribution Channels
    • 3.2.1. Primary Distribution Channels
    • 3.2.2. Secondary Distribution Channels

4. Global Muscle Relaxant Drugs Market Insights

  • 4.1. Muscle Relaxant Drugs Market - Distribution Channel Snapshot
  • 4.2. Muscle Relaxant Drugs Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing geriatric population
      • 4.2.1.2. Increasing prevalence of musculoskeletal disorders
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Adverse effects of muscle relaxants
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Muscle Relaxant Drugs Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Muscle Relaxant Drugs Market, by Drug Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • 5.3. Skeletal Muscle Relaxant Drugs
    • 5.3.1. Global Muscle Relaxant Drugs Market, by Skeletal Muscle Relaxant Drugs, by Region, 2019-2032 (USD Billion)
  • 5.4. Facial Muscle Relaxant Drugs
    • 5.4.1. Global Muscle Relaxant Drugs Market, by Facial Muscle Relaxant Drugs, by Region, 2019-2032 (USD Billion)
  • 5.5. Neuromuscular Blocking Agents
    • 5.5.1. Global Muscle Relaxant Drugs Market, by Neuromuscular Blocking Agents, by Region, 2019-2032 (USD Billion)

6. Global Muscle Relaxant Drugs Market, by Route of Administration

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 6.3. Oral
    • 6.3.1. Global Muscle Relaxant Drugs Market, by Oral, by Region, 2019-2032 (USD Billion)
  • 6.4. Injectable
    • 6.4.1. Global Muscle Relaxant Drugs Market, by Injectable, by Region, 2019-2032 (USD Billion)

7. Global Muscle Relaxant Drugs Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 7.3. Hospital Pharmacy
    • 7.3.1. Global Muscle Relaxant Drugs Market, by Hospital Pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.4. Retail Pharmacy
    • 7.4.1. Global Muscle Relaxant Drugs Market, by Retail Pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.5. Online Pharmacy
    • 7.5.1. Global Muscle Relaxant Drugs Market, by Online Pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.6. Diagnostic Labs
    • 7.6.1. Global Muscle Relaxant Drugs Market, by Diagnostic Labs, By Region, 2019-2032 (USD Billion)

8. Global Muscle Relaxant Drugs Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Muscle Relaxant Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Muscle Relaxant Drugs Market - North America
    • 8.3.1. North America: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.3. North America: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.3.4. Muscle Relaxant Drugs Market - U.S.
      • 8.3.4.1. U.S.: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.3.5. Muscle Relaxant Drugs Market - Canada
      • 8.3.5.1. Canada: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.4. Muscle Relaxant Drugs Market - Europe
    • 8.4.1. Europe: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.4. Muscle Relaxant Drugs Market - UK
      • 8.4.4.1. UK: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.5. Muscle Relaxant Drugs Market - France
      • 8.4.5.1. France: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.6. Muscle Relaxant Drugs Market - Germany
      • 8.4.6.1. Germany: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.7. Muscle Relaxant Drugs Market - Italy
      • 8.4.7.1. Italy: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.8. Muscle Relaxant Drugs Market - Spain
      • 8.4.8.1. Spain: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.9. Muscle Relaxant Drugs Market - Netherlands
      • 8.4.9.1. Netherlands: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.10. Muscle Relaxant Drugs Market - Russia
      • 8.4.10.1. Russia: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.5. Muscle Relaxant Drugs Market - Asia Pacific
    • 8.5.1. Asia Pacific: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.4. Muscle Relaxant Drugs Market - China
      • 8.5.4.1. China: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.5. Muscle Relaxant Drugs Market - India
      • 8.5.5.1. India: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.6. Muscle Relaxant Drugs Market - Malaysia
      • 8.5.6.1. Malaysia: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.7. Muscle Relaxant Drugs Market - Japan
      • 8.5.7.1. Japan: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.8. Muscle Relaxant Drugs Market - Indonesia
      • 8.5.8.1. Indonesia: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.9. Muscle Relaxant Drugs Market - South Korea
      • 8.5.9.1. South Korea: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.6. Muscle Relaxant Drugs Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.4. Muscle Relaxant Drugs Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.5. Muscle Relaxant Drugs Market - UAE
      • 8.6.5.1. UAE: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.6. Muscle Relaxant Drugs Market - Israel
      • 8.6.6.1. Israel: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.7. Muscle Relaxant Drugs Market - South Africa
      • 8.6.7.1. South Africa: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.7. Muscle Relaxant Drugs Market - Latin America
    • 8.7.1. Latin America: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.7.4. Muscle Relaxant Drugs Market - Mexico
      • 8.7.4.1. Mexico: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.7.5. Muscle Relaxant Drugs Market - Brazil
      • 8.7.5.1. Brazil: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.7.6. Muscle Relaxant Drugs Market - Argentina
      • 8.7.6.1. Argentina: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Amneal Pharmaceuticals
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Drug Type Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Ipsen Biopharmaceuticals
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Drug Type Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Merz Pharmaceuticals
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Drug Type Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Par Pharmaceutical
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Drug Type Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Endo Pharmaceuticals
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Drug Type Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Vertical Pharmaceuticals
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Drug Type Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Mallinckrodt
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Drug Type Benchmarking
    • 10.7.4. Recent Development
  • 10.8. SteriMax
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Drug Type Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Eisai Co.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Drug Type Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Metacel Pharmaceuticals
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Drug Type Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Metacel Pharmaceuticals
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Drug Type Benchmarking
    • 10.11.4. Recent Development

List of Tables

  • Table 1 Global Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 2 Global Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 3 Global Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 4 Muscle Relaxant Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 6 North America: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 7 North America: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 8 U.S.: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 10 U.S.: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 11 Canada: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 13 Canada: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 14 Europe: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 16 Europe: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 17 UK: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 18 UK: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 19 UK: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 20 France: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 21 France: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 22 France: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 23 Germany: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 25 Germany: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 26 Italy: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 28 Italy: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 29 Spain: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 31 Spain: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 35 Russia: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 37 Russia: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 41 China: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 42 China: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 43 China: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 44 India: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 45 India: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 46 India: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 50 Japan: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 52 Japan: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 56 South Korea: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 58 South Korea: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 65 UAE: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 67 UAE: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 68 Israel: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 70 Israel: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 71 South Africa: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 73 South Africa: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 74 Latin America: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 76 Latin America: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 77 Mexico: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 79 Mexico: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 80 Brazil: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 82 Brazil: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 83 Argentina: Muscle Relaxant Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Muscle Relaxant Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 85 Argentina: Muscle Relaxant Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Muscle Relaxant Drugs Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Route of Administration
  • Figure 7. Global Muscle Relaxant Drugs Market, by Route of Administration, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Drug Type
  • Figure 9. Global Muscle Relaxant Drugs Market, by Drug Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Muscle Relaxant Drugs Market, by Distribution Channel, 2022 & 2032 (USD Billion)
  • Figure 12. Muscle Relaxant Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Muscle Relaxant Drugs Market